WeLeader Biomedical Co., Ltd. (TPEX:7713)
70.50
-0.30 (-0.42%)
Nov 20, 2026, 1:24 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.21 billion as of November 20, 2026. It is the 24,745th most valuable company in the world and the 1,222nd biggest in Taiwan. Its market cap has decreased by 3.95% in one year.
Market Cap
3.21B
Enterprise Value
4.09B
Revenue
1.27B
Global Rank
Country Rank
#1,222 Taiwan
PE Ratio
13.58
ChartMarket Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.21B, a decrease of -6.53%. That is a compound annual growth rate of -2.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.21B | -3.95% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| United Orthopedic | 6.46B |
| Hi-Clearance | 5.54B |
| InnoCare Optoelectronics | 5.37B |
| Delta Asia International | 4.99B |
| Apex Biotechnology | 2.80B |
| Bonraybio | 2.67B |
| Wellell | 2.43B |
| A Plus Biotechnology | 2.41B |